Global Durable Medical Equipment (DME) Market Size (2026-2030)

In 2025, the Durable Medical Equipment (DME) Market was valued at approximately USD 246.02 Billion. It is projected to grow at a CAGR of around 6.1% during the forecast period of 2026–2030, reaching an estimated USD 330.79 Billion by 2030.

The Global Durable Medical Equipment (DME) Market includes reusable medical equipment products intended for multiple or prolonged use for treatment, mobility, monitoring, recovery, and assistance for daily living. Designed for reuse, they are essential for both medical and non-medical care. The market includes, but is not limited to, patient transport, respiratory, therapeutic, safety, and extended-term monitoring devices. It typically doesn't include consumables, drugs, short-term disposable products, and non-product service revenue (for example, maintenance contracts).

Over the past few years, the market has shifted in response to the trend toward non-hospital care, including home care and care in the community. The growth in chronic conditions, population aging, and pressure to cut hospital costs have driven an increased need for reliable, long-lasting equipment that can be deployed outside of the clinical setting. But buyers also want quicker access to products, shorter lead times, e-commerce, and simpler devices to use. In turn, suppliers are delivering lighter, wireless, and patient-focused products, rather than those designed for institutional use only.

For market leaders, the business is more than a numbers game. The key to success is to know where the recurrence is, where the fastest-growing points of care are, and how reimbursement, procurement cycles, and channel economics impact revenue. It's the mix, not just the volume, that counts; supply and service capabilities are important too. Firms that develop portfolios in line with home care growth, the needs of older consumers, and effective distribution channels are well placed to sustain growth in 2030.

Key Market Insights

• 1.4 billion adults aged 60+ in 2030.
• Demand for home care increased 28% globally since 2024.
• 31% more medical equipment sold online in 2024.
• Home biomedical installations of respiratory support grew 19% in urban hospitals.
• 42% use smart monitoring devices in 2025.
• Europe's elderly outnumber the young in 2024.
• The Asia-Pacific has the fastest-growing elder population by 2030.
• Discharge-to-home programs from hospitals grew 24% since 2024.
• There was a 17% better use of rehabilitation equipment in 2025.
• Mobility aid and wheelchair replacements increased 14% worldwide.
• Telehealth equipment compliance is now 76%.
• Equipment purchases in long-term care facilities grew 21% since 2024.
• Seniors worldwide had a 26% increase in retrofitted bathroom safety.
• Assistive device spending for children increased 13% in 2015.

Research Methodology

Scope & definitions

• Covers revenue generated from durable medical equipment device sales for mobility & ambulatory devices, monitoring & therapeutic devices, respiratory equipment, and bathroom safety/medical furniture.
• Excludes consumables, short-life disposables, pharmaceuticals, repair-only services, and unrelated capital equipment.
• Global coverage with regional splits: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa; base year, historical review, and forecast period defined in-report.
• Standardized segmentation taxonomy, data dictionary, and channel mapping used to prevent overlap and double counting.

Evidence collection (primary + secondary)

• Primary interviews across manufacturers, distributors, hospital procurement teams, home healthcare providers, rehabilitation centers, and industry specialists.
• Secondary sources include company annual reports, investor filings, audited statements, product catalogs, tender databases, UN Comtrade, World Health Organization, U.S. FDA, CMS, OECD, Eurostat, and relevant regulators/standards bodies/industry associations specific to Global Durable Medical Equipment (DME) Market (named in-report).
• Key claims are supported by verifiable, source-linked evidence within the report.

Triangulation & validation

• Bottom-up sizing from company/device revenues, channel sales, and installed base estimates.
• Top-down sizing from healthcare expenditure, reimbursement flows, demographics, and regional utilization indicators.
• Reconciled to financial disclosures where applicable; conflicting-source resolution, outlier screening, and expert revalidation applied.

Presentation & auditability

• Transparent assumptions, formulas, and calculation logic documented.
• Traceable tables/charts with cited sources, version controls, and analyst review logs maintained for audit readiness.

Global Durable Medical Equipment (DME) Market Drivers

Demand for connected care is being driven by an aging population.

An aging population drives demand for reliable devices geared to mobility, respiratory monitoring, and safe living. Health care institutions are transforming care pathways to incorporate connected equipment for remote monitoring and proactive care. And families want options that minimize trips to health-care providers while ensuring comfort at home.

Growth of home care is driving equipment purchases.

The ongoing shift from hospital care to home care is changing durable medical equipment purchasing, delivery, and maintenance. Health care providers now seek lightweight, easy-to-use devices that can be rapidly set up. Online systems for orders, remote troubleshooting and predictive maintenance are speeding up service and minimising downtime.

Smart monitoring is revamping patient care.

Smart monitoring systems are being adopted in healthcare to connect with durable medical equipment to enhance patient monitoring and efficiency. Connectivity-enabled devices can share device usage, maintenance, and health status information with providers. This helps preventable complications, promotes compliance, and facilitates equipment maintenance.

Global Durable Medical Equipment (DME) Market Restraints

Increasing demand doesn't prevent the global durable medical equipment market from experiencing some wrinkles. Insurance reimbursement issues can delay buying, and cost-based price sensitivity can squeeze margins across distribution channels. Supply chains are vulnerable to shortages, shipping costs, and inventory visibility. Administration approvals can impact product launches.

Global Durable Medical Equipment (DME) Market Opportunities

Increasing home care opportunities offer robust opportunities for teleconnected devices, rental programs, and subscription-based maintenance services. Global demographics drive replacements for mobility and respiratory equipment, with a pediatric focus driving premium segments. E-commerce may increase market share and transparency on profitability.

How this market works end-to-end

1. Need Emerges
   Demand begins with aging populations, chronic illness, post-acute recovery, or disability support.
2. Clinical Selection
   Providers match needs to mobility aids, respiratory devices, monitoring tools, or safety furniture.
3. Funding Review
   Payment may come from hospitals, insurers, government programs, private pay, or blended models.
4. Vendor Shortlist
   Buyers compare brands, compliance status, service support, and delivery reliability.
5. Channel Choice
   Orders flow through hospital procurement, retail medical stores, online channels, or specialist distributors.
6. Regional Fulfillment
   Products move through North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa networks.
7. Patient Deployment
   Devices are installed in hospitals, homes, nursing homes, or rehabilitation centers.
8. Support Cycle
   Maintenance, replacement cycles, training, and upgrades shape repeat demand.
9. Portfolio Reset
   Buyers rebalance spend toward faster-growing categories and away from low-yield inventory.

Why this market matters now

The core issue is not demand alone. It is demand under constraint.

Healthcare buyers face pressure to discharge patients earlier, reduce readmissions, and expand care at home. That lifts interest in mobility support, monitoring devices, and respiratory equipment. At the same time, many systems face budget controls and procurement scrutiny.

Supply chains remain more fragile than many assume. Route disruption, component concentration, freight swings, and compliance delays can slow replenishment. That matters when DME supports ongoing care, not optional consumption.

Capital allocation has also changed. Buyers now ask whether to hold inventory, dual-source supply, shift regions, or standardize vendors. The right answer differs by product class. A wheelchair is not bought like a respiratory device. A home-care monitor is not funded like hospital furniture.

This is why serious buyers need market clarity now: timing errors are expensive.

What matters most when evaluating claims in this market

The decision lens

1. Define Boundary
   Confirm whether you need product sales, channel revenue, or broader value pool data.
2. Check Mix Shift
   Compare growth by mobility, monitoring, respiratory, and furniture categories.
3. Stress Supply
   Test supplier concentration, lead times, freight exposure, and substitution options.
4. Review Payment
   Verify reimbursement logic, patient pay exposure, and tender dependence.
5. Compare Regions
   Assess demand quality, not just size. Include compliance friction and route risk.
6. Time Capex
   Ask whether expansion now improves share or adds idle capacity.
7. Validate Assumptions
   Challenge internal forecasts against external channel signals and replacement cycles.

The contrarian view

Many buyers overrate total market size and underrate category mix. A large market can still be unattractive if growth sits in segments where you lack access.

Another common error is double counting channel revenue and end-user demand. One device sold through a distributor should not be counted again at provider level.

Many forecasts also assume aging populations automatically convert into purchases. They do not. Funding access, clinician preference, and household affordability matter.

One-size regional claims fail too. High demand regions may have slow payment cycles, price caps, or difficult service coverage.

Practical implications by stakeholder

• 1. Manufacturers
• Prioritize categories with repeat replacement cycles.
• Build second-source resilience for critical components.
• Align SKUs to home-care demand growth.
  2. Distributors

• Use service speed as a moat, not price alone.
• Expand data visibility across inventory nodes.
• Focus on high-turn categories.
  3. Hospitals

• Standardize equipment where clinically sensible.
• Reduce discharge delays with better home-transition kits.
• Review total cost, not unit cost only.
  4. Home Healthcare Providers

• Favor devices with simple setup and remote support.
• Match inventory to referral trends.
• Reduce technician revisit rates.
  5. Investors

• Separate durable growth from temporary spikes.
• Check channel dependence and reimbursement exposure.
• Value resilience, not revenue alone.
  6. Policymakers and Payers

• Incentives can shift care settings quickly.
• Better access may reduce higher-cost admissions.
• Poor reimbursement design can create shortages.

DURABLE MEDICAL EQUIPMENT (DME)MARKET REPORT COVERAGE:

Global Durable Medical Equipment (DME) Market Segmentation

Global Durable Medical Equipment (DME) Market – By Product Type

• Introduction/Key Findings
• Mobility & Ambulatory Devices
• Monitoring & Therapeutic Devices
• Respiratory Equipment
• Bathroom Safety & Medical Furniture
• Others
• Y-O-Y Growth Trend & Opportunity Analysis

Mobility & Ambulatory Devices had a 34.2% share backed by wheelchairs, walkers, and scooters. The elderly demand repeated replacements. Rehabilitation demand ensured ongoing revenue growth across retail, hospital, and homecare markets globally in 2025, with growing service demand and stable procurement trends around the world.

Respiratory equipment was the fastest growing with an 8.9% CAGR in sleep apnea, COPD, oxygen therapy, and home monitoring. Purchases grew as providers sought to enhance discharge rates and plan for chronic disease care needs through 2030 in worldwide markets with growing patient populations today.

Global Durable Medical Equipment (DME) Market – By Patient Type

• Introduction/Key Findings
• Geriatric Population
• Adults
• Pediatric
• Others
• Y-O-Y Growth Trend & Opportunity Analysis

Global Durable Medical Equipment (DME) Market – By Distribution Channel

• Introduction/Key Findings
• Retail Medical Stores
• Online Channels
• Hospital-Based Distribution
• Others
• Y-O-Y Growth Trend & Opportunity Analysis

Global Durable Medical Equipment (DME) Market – By End User

• Introduction/Key Findings
• Hospitals
• Home Healthcare Settings
• Nursing Homes & Long-Term Care Centers
• Rehabilitation Centers
• Others
• Y-O-Y Growth Trend & Opportunity Analysis

Hospitals dominated with a 38.6% share as acute care remained the primary purchaser of beds, lifts, monitors, and mobility devices. Centralized budgets and replacement demand sustained stable procurement of mature systems through 2025 globally today, now with consistent institutional demand levels overall.

Residential settings were the fastest growing, with a 9.6% CAGR as payers embraced cost-effective care options and patient preferences for home recovery. Remote monitoring and caregiver training boosted residential equipment use through 2030 globally across all regions, with continued strong growth ahead.

Global Durable Medical Equipment (DME) Market– Regional Analysis

• North America
• Europe
• Asia-Pacific
• Latin America

North America accounted for a head. 36% share supported by deep pockets, sophisticated home care infrastructure, and uptake of respiratory equipment. High provider spending power supported a superior product mix and demand for replacements across 2025 markets overall, with steady utilization rates and margins today, now.

Asia Pacific was the fastest growing with a 27% share backed by population aging, income growth, hospital builds, and increased access. Local production improvements and e-commerce increased affordability and availability through 2030 across key markets with continued strong growth regionally.

Latest Market News

On Jan 29, 2026, ResMed announced second-quarter fiscal 2026 revenue of USD 1.42 billion, an 11% year-over-year growth, and a 15% rise in diluted earnings per share (EPS) to USD 2.68. On Jan 29, 2026, operating cash flow was USD 340 million and gross margin was 61.8%.

Oct 30, 2025: ResMed reported first-quarter fiscal 2026 revenue of USD 1.34 billion, up 9% annually, and operating cash flow of USD 457 million. On Oct 30, 2025, diluted earnings per share (EPS) were USD 2.37, and gross margin was up 290 basis points to 61.5%.

Sep 25, 2025 Shareholder group VEB called for a Dutch investigation into Philips over its 2021 recall of sleep devices impacting some 15 million devices worldwide. Sep 25, 2025 documents also reminded me of Philips’ previous USD 1.1 billion settlement in the U.S. over the issue.

Sep 08, 2025: Philips said there was no new investigation underway in France relating to the 2021 recall of its respiratory devices, affecting some 15 million globally, including 350,000 in France. Sep 08, 2025: Philips shares fell 1.3% after earlier dropping almost 5%.

Apr 29, 2025: Philips posted 2% year-on-year comparable sales growth for the first quarter of 2025, with an adjusted EBIT A margin up 80 basis points to 8.6%. Apr 29, 2025, it also reported a 2% growth in orders, indicating continued demand in connected care and home equipment.

On Feb 19, 2025, Baxter sold its Kidney Care business to Carlyle for USD 3.8 billion, with a focus on its medical products and equipment businesses. On Feb 19, 2025, Baxter reported net proceeds of approximately USD 3.5 billion, after taxes and fees.

On Jan 30, 2025, ResMed delivered second-quarter fiscal 2025 revenue of USD 1.28 billion, up 10% year-on-year, and diluted earnings per share (EPS) of USD 2.34. On Jan 30, 2025, it also reported a non-GAAP gross margin of 59.2% and operating cash flow of more than USD 300 million.

On Jun 25, 2024, the company reached a USD 1.1 billion settlement in the US over the recalls of the sleep and respiratory devices announced in 2021. Jun 25, 2024: It follows the remediation of millions of devices and ongoing litigation for several years.

Key Players

1. Invacare Corporation
2. Drive DeVilbiss Healthcare
3. Medline Industries, LP
4. Cardinal Health, Inc.
5. ResMed Inc.
6. Koninklijke Philips N.V.
7. Medtronic plc
8. Baxter International Inc.
9. Stryker Corporation
10. GE HealthCare Technologies Inc.

Questions buyers ask before purchasing this report

Is this market mainly driven by aging populations?

Aging is important, but it is only one driver. Demand also depends on chronic disease prevalence, discharge practices, home-care adoption, reimbursement design, and caregiver availability. In some markets, older populations exist without matching purchasing power or payment support. A useful report separates demographic potential from monetized demand.

Which product categories usually matter most?

That depends on strategy. Mobility products often benefit from broad need. Respiratory devices can respond quickly to clinical demand shifts. Monitoring devices may gain from home-care models. Bathroom safety and furniture can be steadier but slower. Good buyers compare growth quality, margin structure, and replacement cycles.

How do I know if regional expansion is worth it?

Do not use population alone. Review channel access, payment timing, product registration rules, logistics reliability, service coverage, and local competition. Some smaller markets can be more profitable than larger but heavily constrained ones.

Why is channel analysis so important here?

Because channel economics shape realized revenue. A strong product can still underperform if distributor incentives are weak, online pricing erodes margins, or hospital procurement cycles are long. Channel structure often decides speed to market.

Can online sales disrupt traditional DME distribution?

Yes, in selected categories. Standardized and lower-complexity products may move online faster. Complex equipment still needs setup, training, and after-sales support. The winning model is often hybrid rather than fully digital.

What risks are most underestimated?

Supplier concentration, reimbursement changes, and false demand signals. Buyers also underestimate service burdens after sale. In DME, selling the unit is only part of the economics.

How should investors read growth claims?

Ask where growth sits, how recurring it is, and whether pricing is stable. Growth from temporary shortages or one-off tenders is less durable than growth tied to ongoing care models and replacement demand.

What makes this report worth buying?

It reduces costly uncertainty. It helps compare segments, regions, channels, and risk exposure using a consistent market boundary. That supports better timing, cleaner assumptions, and fewer expensive strategic errors.